PBE | Invesco Dynamic Biotechnology & Genome ETF Overview

(Stock Exchange: AMEX)

Day's Range	68.17 - 69.17
52 Week Range	53.16 - 72.72
Beta	0.78
Implied Volatility	17.29%
IV Rank	60.43%
Day's Volume	4,467
Average Volume	6,493
Shares Outstanding	4,550,000
Inception Date	2005-06-23

Assets	262,108,800
Asset Class	Equity
Expense Ratio	0.59
P/E Ratio	18.20
EPS	3.77
Dividend Yield	0.05%
Dividend Per Share	0.03
Dividend ExDate	N/A
Dividend PayDate	N/A

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

*Chart delayed

Watching at PBE technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on PBE Technicals page.